Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 17, 2008 - Issue 10
Submit an article Journal homepage
350
Views
37
CrossRef citations to date
0
Altmetric
Review

Statins: under investigation for increasing bone mineral density and augmenting fracture healing

Quen Oak Tang University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
,
Gui Tong Tran University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
,
Zakareya Gamie University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
,
Simon Graham University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
,
Evaggelos Tsialogiannis University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
,
Evgenios Tsiridis Blue Cross Hospital, Cardio-Thoracic Anaesthetic Unit, Thessaloniki, Greece
,
Tobias Linder University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
&
Eleftherios Tsiridis University of Leeds School of Medicine, Leeds General Infirmary Teaching HospitalsNHS Trust, Academic Department of Trauma and Orthopaedics, Great George Street, Clarendon Wing A, Leeds, LS1 3EX, UK +44 113 392 2621; +44 113 392 3290; [email protected]
 show all
Pages 1435-1463 | Published online: 22 Sep 2008

Bibliography

  • Court-Brown CM, Caesar B. Epidemiology of adult fractures: a review. Injury 2006;37(8):691-7
  • Orosz GM, Magaziner J, Hannan EL, et al. Association of timing of surgery for hip facture and patient outcomes. JAMA 2004;291(14):1738-43
  • Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001;81(1):153-208
  • Laufs U, Liao JK. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med 2000;10(4):143-8
  • Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335(14):1001-9
  • Sugiyama M, Kodama T, Konishi K, et al. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 2000;271(3):688-92
  • Hatano H, Maruo A, Bolander ME, Sarkar G. Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci 2003;8(6):842-8
  • Maeda T, Matsunuma A, Kurahashi I, et al. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 2004;92(3):458-71
  • Ohno T, Shigetomi M, Ihara K, et al. Skeletal reconstruction by vascularized allogenic bone transplantation: effects of statin in rats. Transplantation 2003;76(5):869-71
  • Ruiz-Gaspa S, Nogues X, Enjuanes A, et al. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem 2007;101(6):1430-8
  • Song C, Guo Z, Ma Q, et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003;308(3):458-62
  • Thunyakitpisal PD, Chaisuparat R. Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells. J Pharmacol Sci 2004;94(4):403-9
  • Wong RW, Rabie AB. Early healing pattern of statin-induced osteogenesis. Br J Oral Maxillofac Surg 2005;43(1):46-50
  • Gutierrez GE, Lalka D, Garrett IR, et al. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int 2006;17(7):1033-42
  • Serin-Kilicoglu S, Erdemli E. New addition to the statin's effect. J Trauma 2007;63(1):187-91
  • Skoglund B, Aspenberg P. Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet Disord 2007;8:98
  • Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 2007;18(12):1641-50
  • Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003;88(5):873-84
  • Tardif G, Hum D, Pelletier JP, et al. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 2004;50(8):2521-30
  • Matthews SJ. Biological activity of bone morphogenetic proteins (BMP's). Injury 2005;36(Suppl 3):S34-7
  • Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 1998;22(6):591-603
  • Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 2001;83-A(Suppl 1)(Pt 1):S1-6
  • Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A8:1544-52
  • Bostrom MP. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res1998;(355 Suppl):S116-23
  • Swiontkowski MF, Aro HT, Donell S, et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 2006;88(6):1258-65
  • Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A12:2123-34
  • Rickard DJ, Sullivan TA, Shenker BJ, et al. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994;161(1):218-28
  • Xiao G, Gopalakrishnan R, Jiang D, et al. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17(1):101-10
  • Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene 2005;357(1):1-8
  • Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: which are the important molecules? Injury 2007;38(Suppl 1):S11-25
  • Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18(1):4-25
  • Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152(8):4149-56
  • Bouletreau PJ, Warren SM, Spector JA, et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002;109(7):2384-97
  • Reponen P, Sahlberg C, Munaut C, et al. High expression of 92-kDa type IV collagenase (gelatinase) in the osteoclast lineage during mouse development. Ann NY Acad Sci 1994;732:472-5
  • Colnot C, Thompson Z, Miclau T, et al. Altered fracture repair in the absence of MMP9. Development 2003;130(17):4123-33
  • Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286(5446):1946-9
  • Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 2003;144(2):681-92
  • Zhao M, Xiao G, Berry JE, et al. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res 2002;17(8):1441-51
  • Hess DC, Demchuk AM, Brass LM, Yatsu FM. HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology 2000;54(4):790-6
  • Yoshida T, Asanuma M, Grossmann L, et al. Geranylgeranyl-pyrophosphate (GGPP) synthase is down-regulated during differentiation of osteoblastic cell line MC3T3-E1. FEBS Lett 2006;580(22):5203-7
  • Coxon FP, Helfrich MH, Van't Hof R, et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 2000;15(8):1467-76
  • Massy ZA, Keane WF, Kasiske BL. Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet 1996;347(8994):102-3
  • Corsini A, Bellosta S, Baetta R, et al. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 1999;84(3):413-28
  • Corsini A, Maggi FM, Catapano AL. Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 1995;31(1):9-27
  • McTaggart F, Buckett L, Davidson R, et al. Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol 2001;87(5A):28B-32B
  • Kajinami K, Mabuchi H, Saito Y. NK-104: a novel synthetic HMG-CoA reductase inhibitor. Expert Opin Investig Drugs 2000;9(11):2653-61
  • Christians U, Jacobsen W, Floren LC. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Ther 1998;80(1):1-34
  • Appel S, Dingemanse J. Clinical pharmacokinetics of fluvastatin with reference to other HMG-CoA reductase inhibitors. Drugs Today 1996;32(Suppl A):37-55
  • Dain JG, Fu E, Gorski J, et al. Biotransformation of fluvastatin sodium in humans. Drug Metab Dispos 1993;21(4):567-72
  • Martin PD, Mitchell PD, Schneck DW. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. Br J Clin Pharmacol 2002;54(5):472-7
  • Pan HY, DeVault AR, Wang-Iverson D, et al. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J Clin Pharmacol 1990;30(12):1128-35
  • Black DM. A general assessment of the safety of HMG CoA reductase inhibitors (statins). Curr Atheroscler Rep 2002;4(1):34-41
  • Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 2005;19(1):117-25
  • Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341(7):498-511
  • Singhvi SM, Pan HY, Morrison RA, Willard DA. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br J Clin Pharmacol 1990;29(2):239-43
  • Martin PD, Warwick MJ, Dane AL, et al. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. Clin Ther 2003;25(10):2553-63
  • Nakagawa M, Kaneda T, Arakawa T, et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 2000;473(2):161-4
  • Risau W. Mechanisms of angiogenesis. Nature 1997;386(6626):671-4
  • Garrett IR, Gutierrez GE, Rossini G, et al. Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J Orthop Res 2007;25(10):1351-7
  • Staal A, Frith JC, French MH, et al. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 2003;18(1):88-96
  • Sonobe M, Hattori K, Tomita N, et al. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture. Biomed Mater Eng 2005;15(4):261-7
  • Ohno T, Shigetomi M, Ihara K, et al. Effects of cerivastatin on vascularized allogenic bone transplantation in rats treated with cyclosporine A. Calcif Tissue Int 2003;72(1):50-6
  • Sinzinger H, Wolfram R, Peskar BA. Muscular side effects of statins. J Cardiovasc Pharmacol 2002;40(2):163-71
  • Matzno S, Tazuya-Murayama K, Tanaka H, et al. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis. J Pharm Pharmacol 2003;55(6):795-802
  • Lee Y, Schmid MJ, Marx DB, et al. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials 2008;29(12):1940-9
  • Kawane T, Terashima S, Kurahashi I, et al. Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone (1-34). Endocrine 2004;24(2):121-9
  • Maritz FJ, Conradie MM, Hulley PA, et al. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol 2001;21(10):1636-41
  • Von Stechow D, Fish S, Yahalom D, et al. Does simvastatin stimulate bone formation in vivo? BMC Musculoskelet Disord 2003;4:8
  • Bauer DC, Mundy GR, Jamal SA, et al. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med 2004;164(2):146-52
  • Rejnmark L, Buus NH, Vestergaard P, et al. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 2004;19(5):737-44
  • Lupattelli G, Scarponi AM, Vaudo G, et al. Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism 2004;53(6):744-8
  • Uzzan B, Cohen R, Nicolas P, et al. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 2007;40(6):1581-7
  • Kuzuya M, Suzuki Y, Asai T, et al. Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly. J Am Geriatr Soc 2003;51(11):1677-8
  • Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 2001;12(5):380-4
  • Watanabe S, Fukumoto S, Takeuchi Y, et al. Effects of 1-year treatment with fluvastatin or pravastatin on bone. Am J Med 2001;110(7):584-7
  • Stein EA, Farnier M, Waldstreicher J, Mercuri M. Effects of statins on biomarkers of bone metabolism: a randomised trial. Nutr Metab Cardiovasc Dis 2001;11(2):84-7
  • Kajinami K, Takekoshi N, Matsui S, et al. Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 2003;92(9):1113-6
  • Berthold HK, Unverdorben S, Zittermann A, et al. Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int 2004;15(6):459-67
  • Rosenson RS, Tangney CC, Langman CB, et al. Short-term reduction in bone markers with high-dose simvastatin. Osteoporos Int 2005;16(10):1272-6
  • Majima T, Komatsu Y, Fukao A, et al. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. Endocr J 2007;54(1):145-51
  • Rejnmark L, Buus NH, Vestergaard P, et al. Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest 2002;32(8):581-9
  • Pedersen TR, Kjekshus J. Statin drugs and the risk of fracture. 4S Study Group. Jama 2000;284(15):1921-2
  • Reid IR, Hague W, Emberson J, et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet 2001;357(9255):509-12
  • Nguyen ND, Wang CY, Eisman JA, Nguyen TV. On the association between statin and fracture: a Bayesian consideration. Bone 2007;40(4):813-20
  • Hatzigeorgiou C, Jackson JL. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis. Osteoporos Int 2005;16(8):990-8
  • Toh S, Hernandez-Diaz S. Statins and fracture risk. A systematic review. Pharmacoepidemiol Drug Saf 2007;16(6):627-40
  • Bone HG, Kiel DP, Lindsay RS, et al. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial. J Clin Endocrinol Metab 2007;92(12):4671-7
  • Armitage J. The safety of statins in clinical practice. Lancet 2007;370(9601):1781-90
  • Sanchez CA, Rodriguez E, Varela E, et al. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest 2008;26(7):698-707
  • Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005;26(5):883-91
  • Masters BA, Palmoski MJ, Flint OP, et al. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes. Toxicol Appl Pharmacol 1995;131(1):163-74
  • Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;143(4):1545-53
  • Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002;99(15):9656-61
  • Vu TH, Shipley JM, Bergers G, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93(3):411-22
  • Delaisse JM, Engsig MT, Everts V, et al. Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta 2000;291(2):223-34
  • Holliday LS, Welgus HG, Fliszar CJ, et al. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 1997;272(35):22053-8
  • Solomon DH, Finkelstein JS, Wang PS, Avorn J. Statin lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Saf 2005;14(4):219-26
  • Tikiz C, Tikiz H, Taneli F, et al. Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study. Clin Rheumatol 2005;24(5):447-52
  • Yamazaki M, Suzuki H, Hanano M, et al. Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 1993;264(1 Pt 1):G36-44
  • Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002;41(5):343-70
  • Mundy GR. Statins and their potential for osteoporosis. Bone 2001;29(6):495-7
  • Hughes A, Rogers MJ, Idris AI, Crockett JC. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Calcif Tissue Int 2007;81(5):403-13
  • Woo JT, Kasai S, Stern PH, Nagai K. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res 2000;15(4):650-62
  • Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998;(355 Suppl):S7-21
  • Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002;17(3):513-20
  • Yamagiwa H, Tokunaga K, Hayami T, et al. Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. Bone 1999;25(2):197-203
  • Fall PM, Kennedy D, Smith JA, et al. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Osteoporos Int 2000;11(6):481-5
  • Grasser WA, Baumann AP, Petras SF, et al. Regulation of osteoclast differentiation by statins. J Musculoskelet Neuronal Interact 2003;3(1):53-62
  • Kaji H, Kanatani M, Sugimoto T, Chihara K. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures. Horm Metab Res 2005;37(10):589-92
  • Mendoza S, Noa M, Mas R, Mendoza N. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats. Drugs Exp Clin Res 2005;31(5-6):181-91
  • Liggett SB. Genetically modified mouse models for pharmacogenomic research. Nat Rev Genet 2004;5(9):657-63
  • Webster A, Martin P, Lewis G, Smart A. Integrating pharmacogenetics into society: in search of a model. Nat Rev Genet 2004;5(9):663-9
  • Weinshilboum R, Wang L. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 2004;3(9):739-48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.